1. Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome 
Rebecca A. Feldman, M.D., Kathleen O'Neill, M.D., Samantha F. Butts, M.D., M.S.C.E., Anuja Dokras, M.D., Ph.D. 
Fertility and Sterility 
Volume 107, Issue 1, Pages (January 2017)
DOI: /j.fertnstert
Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions

2. Figure 1
Correlations between antimüllerian hormone (AMH) and selected biomarkers of cardiometabolic risk in women with polycystic ovary syndrome (PCOS). BMI = body mass index; BP = blood pressure; HOMA = homeostasis-model assessment of insulin resistance.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2016 American Society for Reproductive Medicine Terms and Conditions